Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana

Clinical Infectious Diseases

Volumn 43, Issue 12, 2006, Pages 1612-1615

  Wester, C William ^a,c   Bussmann, Hermann ^a,c   Moyo, Sikhulile ^a   Avalos, Ava ^a,c   Gaolathe, Tendani ^b   Ndwapi, Ndwapi ^b   Essex, Max ^a,c   MacGregor, Rob Roy ^d   Marlink, Richard G ^a,c  

^a BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^b PRINCESS MARINA HOSPITAL   (Botswana)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BOTSWANA; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS INFECTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TOXOPLASMA GONDII;

ADULT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BOTSWANA; CYTOMEGALOVIRUS INFECTIONS; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; SYPHILIS;

EID: 33845445837     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/508865     Document Type: Article

References (31)

1. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users: association with drug injection patterns. Am J Epidemiol 1995; 142:331-41.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337:1733-45.
3. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655-61.
4. Van Ameijden EJ, Van den Hoek JA, Mientjes GH, Coutinho RA. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993; 9:255-62.
5. Makris M, Preston FE, Triger DR, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335:1117-9.
6. Rumi MG, Colombo M, Gringeri A, Mannucci PM. High prevalence of antibody to hepatitis C virus in multi-transfused hemophiliacs with normal transaminase levels. Ann Intern Med 1990; 112:379-80.
7. Alter MJ, Hadler SC, Judson FN, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264:2231-5.
8. Conry-Cantilena C, van Raden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334:1691-6.
9. Gordon SC, Patel AH, Kulesza GW, Barnes RE, Silverman AL. Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 1992; 87:1849-51.
10. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lancet 1995; 345:289-91.
11. Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53:1-112. Erratum in: MMWR Morb Mortal Wkly Rep 2005; 54:311.
12. Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 2001; 33:562-9.
13. Benhamou Y, Bochet M, Di Martino V, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus co-infected patients. The Multivirc Group. Hepatology 1999; 30:1054-8.
14. Calza L, Manfredi R, Marinacci G, et al. Efficacy of penicillin G benzathine as antimicrobial treatment of cutaneous secondary syphilis in patients with HIV infection. J Chemother 2002; 14:533-4.
15. Rompalo AM, Lawlor J, Seaman P, et al. Modification of syphilitic genital ulcer manifestations by co-existent HIV infection. Sex Transm Dis 2001; 28:448-54.
16. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Int Med 1990; 113:872-81.
17. Ndumbe PM, Andela A, Nkemnkeng-Asong J, Watonsi E, Nyambi P. Prevalence of infections affecting the child among pregnant women in Yaounde, Cameroon. Med Microbiol Immunol (Berl) 1992; 181:127-30.
18. Rahlenbeck SI, Yohannes G, Molla K, Reifen K, Assefa A. Infection with HIV, syphilis and hepatitis B in Ethiopia: a survey in blood donors. Int J STD AIDS 1997; 8:261-4.
19. de Lalla F, Rizzardini G, Rinaldi E, Santoro D, Zeli PL, Verga G. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas. Trans R Soc Trop Med Hyg 1990; 84:144-7.
20. Lepers JP, Billon C, Pesce JL, Rollin PE, De Saint-Martin J. Seroepidemiological study in Mauritania (1985-1986): incidence of treponematosis, hepatitis B virus, HIV virus and viral hemorrhagic fevers. Bull Soc Pathol Exot Filiales 1988; 81:24-31.
21. Hladik W, Kataaha P, Mermin J, et al. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors. Trop Med Int Health 2006; 11:951-4.
22. Msuya SE, Mbizvo EM, Hussain A, Sam NE, Stray-Pedersen B. Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban, Tanzania. East Afr Med J 2006; 83:91-4.
23. Simpore J, Savadogo A, Ilboudo D, et al. Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso. J Med Virol 2006; 78:730-3.
24. Adjei AA, Armah HB, Gbagbo F, et al. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Virol 2006; 78:683-92.
25. Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at eh Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health 2006; 6:21.
26. Paz-Bailey G, Rahman M, Chen C, et al. Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin Infect Dis 2005; 41:1304-12.
27. Ministry of State President, the National AIDS Coordinating Agency. Botswana 2003 second generation HIV/AIDS surveillance: a technical report. 2003:1-89.
28. Department of Health and Human Services, Center for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in HIV-I-infected adults and adolescents. October 2006. Available at: http://AIDSinfo.nih.gov. Accessed 6 November 2006.
29. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clinical Infectious Diseases 2003; 36:652-62.
30. Colvin M, Dawood S, Kleinschmidt I, Mullick S, Lallo U. Prevalence of HIV and HIV-related diseases in the adult medical wards of tertiary hospital in Durban, South Africa. Int J STD AIDS 2001; 12:386-9.
31. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS 2002; 16:1031-8.